Thyroid Cancer Newswire

Thyroid Cancer Newswire

Comprehensive Real-Time News Feed for Thyroid Cancer.

Results 1 - 20 of 659 in Thyroid Cancer

  1. Cancer alters Washougal yoga teacher's courseRead the original story w/Photo

    6 hrs ago | The Columbian

    ... investigate a lump on her throat. There was a chance it was just benign; the results came back positive for thyroid cancer. "I felt a little bit like I was in shock," Cherry, 42, said. "I didn't have a lot of emotion, but I was on my way to work, so ...

    Comment?

  2. Recent Research Analysts' Ratings Changes for Interpace Diagnostics GroupRead the original story w/Photo

    19 hrs ago | AmericanBankingNews.com

    ... the Annual Meeting of the American Thyroid Association (ATA) on the combined use of its molecular tests for thyroid cancer; ThyGenX and ThyraMIR."" 10/11/2018 - Interpace Diagnostics Group was given a new $3.00 price target on by analysts at HC ...

    Comment?

  3. Exelixis, Inc. (EXEL) Insider Sells $430,500.00 in StockRead the original story w/Photo

    Yesterday | IntersportsWire

    ... therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Receive News & Ratings for Exelixis Daily - Enter your email address below to receive a concise daily summary of the latest news ...

    Comment?

  4. Exelixis, Inc. (EXEL) Receives Consensus Recommendation of "Buy" from AnalystsRead the original story w/Photo

    Yesterday | AmericanBankingNews.com

    ... therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Receive News & Ratings for Exelixis Daily - Enter your email address below to receive a concise daily summary of the latest news ...

    Comment?

  5. French Polynesian president acknowledges nuclear test liesRead the original story w/Photo

    Saturday Nov 17 | Pattaya Mail

    ... of the Polynesian nuclear testing who died last year, raised awareness on the disproportionate rates of thyroid cancer and leukemia to hit Polynesia's 280,000 residents. In 2016, then-President Francois Hollande acknowledged during a visit that ...

    Comment?

  6. Lies on French Polynesia nuclear bombs admittedRead the original story w/Photo

    Friday Nov 16 | Dear Kitty

    ... government to the statements by Fritch. The whistleblower Bruno Barrillot, who died last year, revealed that thyroid cancer and leukemia occur excessively among the 280,000 inhabitants of French Polynesia. President Hollande visited French Polynesia ...

    Comment?

  7. Patients with rare, incurable digestive tract cancers respond to new drug combinationRead the original story w/Photo

    Wednesday Nov 14 | EurekAlert!

    ... is a validated target in patients with biliary tract cancer." Research in other cancers, such as melanoma, thyroid cancer and lung cancer, has shown that combinations of drugs that inhibit both the BRAF and MEK cancer pathways can be effective. Dr ...

    Comment?

  8. Dr Aimee Tharaldson: Recently Approved Specialty Drugs, Upcoming Approvals to Watch ForRead the original story w/Photo

    Tuesday Nov 13 | The American Journal of Managed Care

    ... only represents about 3% of cancers, but it's associated with hard-to-treat cancers like pancreatic cancer, thyroid cancer, salivary gland cancer. So, patients can actually be tested for these TRK fusion proteins and we'll have this new option ...

    Comment?

  9. Orem QB Cooper Legas has country's second-most total yards thanks to hard work and 'rubber hips'Read the original story w/Photo

    Monday Nov 12 | Deseret News

    ... brother, Gunnar Legas, was a standout quarterback at Orem, who will enroll at BYU in January after battling thyroid cancer for the last nine months. The cancer was diagnosed while Gunnar was serving a mission in Africa last winter. Cooper said he ...

    Comment?

  10. Analysts' Recent Ratings Updates for ExelixisRead the original story w/Photo

    Monday Nov 12 | AmericanBankingNews.com

    ... therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Receive News & Ratings for Exelixis Inc Daily - Enter your email address below to receive a concise daily summary of the latest ...

    Comment?

  11. Active surveillance for prostate and thyroid cancers: evolution in...Read the original story w/Photo

    Friday Nov 9 | Nature Reviews Clinical Oncology

    ... after the introduction of prostate-specific antigen-based screening are now being observed in those with thyroid cancer, owing to the introduction of new imaging technologies. Thus, the evolving paradigm of active surveillance in prostate and ...

    Comment?

  12. Comparing Response GeneticsRead the original story w/Photo

    Saturday Nov 10 | AmericanBankingNews.com

    ... services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ...

    Comment?

  13. In with the new: UTRGV women's basketball under new directionRead the original story w/Photo

    Saturday Nov 10 | TheMonitor.com

    ... place than a year ago. The Arizona native was cleared to play just before the season after a battle with thyroid cancer that included quarantine, radioactive iodine pills and extreme weight loss. "It was an emotional roller coaster for me to try to ...

    Comment?

  14. Life's a stage for rising comedy star from Eagle RiverRead the original story w/Photo

    Friday Nov 9 | Alaska Star

    ... laugh. What brought Braunstein to Portland was no laughing matter. In 2010 she was diagnosed with metastatic thyroid cancer and went south to seek treatment. She beat cancer and in the process found a vibrant stand-up community that welcomed her ...

    Comment?

  15. $195.01 Million in Sales Expected for Exelixis, Inc. (EXEL) This QuarterRead the original story w/Photo

    Friday Nov 9 | IntersportsWire

    ... ogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Receive News &

    Comment?

  16. Getting a 'fine needle biopsy' of my thyroid on a Wednesday afternoonRead the original story

    Friday Nov 9 | Daily Grit

    My wife Gladys got this shot while I was waiting for the MSU doctor to do the fine needle biopsy of my thyroid. Before poking me more than 10 times in my thyroid which has a goiter the size of an orange, the Michigan State University doctor took some time to talk about thyroid cancer and how the odds were that I didn't have it.

    Comment?

  17. Veracyte to Present at the Canaccord Genuity Medical Technologies & Diagnostics ForumRead the original story w/Photo

    Friday Nov 9 | TriCities.com

    ... founding in 2008, Veracyte has commercialized three genomic tests, which are transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis and collectively target a $2 billion market opportunity. Veracyte is based in ...

    Comment?

  18. ThyroSeq test helps patients avoid unnecessary diagnostic thyroid surgery, study showsRead the original story w/Photo

    Thursday Nov 8 | PhysOrg Weblog

    ... that uniquely evaluates cells collected by FNA from a thyroid nodule for alterations in 112 genes linked to thyroid cancer. It is designed to diagnose all types of thyroid cancer, including Hurthle cell cancer, as well as medullary carcinoma and ...

    Comment?

  19. Low-Dose Radiation Safe for Low-Risk Thyroid CancerRead the original story w/Photo

    Tuesday Nov 6 | Drugs.com

    For patients with low-risk thyroid cancer, low-dose radiation is not associated with an increased risk for recurrence versus high-dose radiation over almost seven years of follow-up, according to a study presented at the 2018 National Cancer Research Institute Cancer Conference, held from Nov. 4 to 6 in Glasgow, Scotland. Jon Wadsley, M.B. B.Chir., from University College London, and colleagues randomly assigned 434 patients with differentiated thyroid cancer to receive either low administered radioactive iodine activity of 1.1 GBq or standard high RAI of 3.7 GBq following surgery, each with either Thyrogen or thyroid hormone withdrawal .

    Comment?

  20. Piper Jaffray Companies Weighs in on Exelixis, Inc.'s Q2 2019 EarningsRead the original story w/Photo

    Tuesday Nov 6 | AmericanBankingNews.com

    ... therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Receive News & Ratings for Exelixis Daily - Enter your email address below to receive a concise daily summary of the latest news ...

    Comment?